In celiac disease, early blood test screening may reduce future mortality risk
In celiac disease, early blood test screening may reduce future mortality risk. Celiac disease (CD) is characterized by gluten intolerance, and although the solution is as simple as avoiding gluten, many individuals do not get diagnosed, which can put their lives at risk. Doctors are now considering screening patients who show early signs and symptoms of celiac disease as well as individuals who are at high risk.
The study examined the viability of screening for celiac disease and found that first-degree relatives of individuals with celiac disease, type 1 diabetes, iron-deficiency anemia, Down’s syndrome, and other high-risk groups should be screened for celiac disease.
Professor Antonio Gasbarrini said, “This important research highlights the value of serological testing for CD in anyone with symptoms that might be due to the condition and in all asymptomatic individuals from high-risk groups. It is vital that we now start to take positive action across Europe to tackle this prevalent condition and reduce its serious health consequences.”
Read more at http://www.belmarrahealth.com/in-celiac-disease-early-blood-test-screening-may-reduce-future-mortality-risk/